Bellerophon Therapeutics Company
Bellerophon focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary diseases.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Warren, New Jersey, United States
Founded Date:
2009
Employees Number:
11-50
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Register and Claim Ownership